» Articles » PMID: 26734788

FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION

Abstract

Background: Liver metastases of colorectal cancer are frequent and potentially fatal event in the evolution of patients with these tumors.

Aim: In this module, was contextualized the clinical situations and parameterized epidemiological data and results of the various treatment modalities established.

Method: Was realized deep discussion on detecting and staging metastatic colorectal cancer, as well as employment of imaging methods in the evaluation of response to instituted systemic therapy.

Results: The next step was based on the definition of which patients would have their metastases considered resectable and how to expand the amount of patients elegible for modalities with curative intent.

Conclusion: Were presented clinical, pathological and molecular prognostic factors, validated to be taken into account in clinical practice.

Citing Articles

The impact of multivisceral liver resection on short- and long-term outcomes of patients with colorectal liver metastasis: A systematic review and meta-analysis.

Junior S, Tustumi F, de Paiva Magalhaes D, Jeismann V, Fonseca G, Pirola Kruger J Clinics (Sao Paulo). 2022; 77:100099.

PMID: 36122500 PMC: 9489954. DOI: 10.1016/j.clinsp.2022.100099.


PRIMARY TUMOR LYMPHOVASCULAR INVASION NEGATIVELY AFFECTS SURVIVAL AFTER COLORECTAL LIVER METASTASIS RESECTION?.

Campanati R, Sancio J, Sucena L, Sanches M, Resende V Arq Bras Cir Dig. 2021; 34(1):e1578.

PMID: 34133525 PMC: 8195463. DOI: 10.1590/0102-672020210001e1578.


Feasibility of Right Upper Transversal Hepatectomy in the Absence of an Inferior Right Hepatic Vein: New Insights regarding This Complex Procedure.

Makdissi F, Pirola Kruger J, Jeismann V, Herman P Case Rep Surg. 2021; 2021:6668269.

PMID: 33747594 PMC: 7960046. DOI: 10.1155/2021/6668269.


Current state of the art imaging approaches for colorectal liver metastasis.

Hazhirkarzar B, Khoshpouri P, Shaghaghi M, Ghasabeh M, Pawlik T, Kamel I Hepatobiliary Surg Nutr. 2020; 9(1):35-48.

PMID: 32140477 PMC: 7026783. DOI: 10.21037/hbsn.2019.05.11.


BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES.

Torres O, Marques M, Santos F, de Farias I, Coutinho A, de Oliveira C Arq Bras Cir Dig. 2016; 29(3):173-179.

PMID: 27759781 PMC: 5074669. DOI: 10.1590/0102-6720201600030011.

References
1.
Fong Y, Cohen A, Fortner J, Enker W, Turnbull A, Coit D . Liver resection for colorectal metastases. J Clin Oncol. 1997; 15(3):938-46. DOI: 10.1200/JCO.1997.15.3.938. View

2.
Kune G, Kune S, Field B, White R, Brough W, Schellenberger R . Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum. 1990; 33(11):938-46. DOI: 10.1007/BF02139103. View

3.
Kopetz S, Chang G, Overman M, Eng C, Sargent D, Larson D . Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009; 27(22):3677-83. PMC: 2720081. DOI: 10.1200/JCO.2008.20.5278. View

4.
Are C, Gonen M, Zazzali K, DeMatteo R, Jarnagin W, Fong Y . The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007; 246(2):295-300. PMC: 1933562. DOI: 10.1097/SLA.0b013e31811ea962. View

5.
Zech C, Korpraphong P, Huppertz A, Denecke T, Kim M, Tanomkiat W . Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Br J Surg. 2014; 101(6):613-21. PMC: 4312911. DOI: 10.1002/bjs.9465. View